Considering the growing interest in the identification of specific markers to assess the diagnosis and prognosis of CRS, we demonstrated altered levels of NT-proBNP, suPAR, galectin-3, sNGAL, and uNGAL in SSc patients compared with HC. The gene discussed is LGALS3; the disease is systemic sclerosis.